We are live on ! Find out more
SC

Scholtz & Company Portfolio holdings

AUM $195M
1-Year Est. Return 12.04%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$95M
AUM Growth
+$1.45M
Cap. Flow
-$2.59M
Cap. Flow %
-2.72%
Top 10 Hldgs %
46.44%
Holding
53
New
6
Increased
22
Reduced
12
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 24.18%
2 Financials 15.24%
3 Consumer Discretionary 14.41%
4 Communication Services 12.39%
5 Technology 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FGL
51
DELISTED
Fidelity & Guaranty Life
FGL
-21,500
Closed -$528K

Similar funds

Scholtz & Company's Q4 2015 Portfolio in Review

As of Q4 2015, Scholtz & Company held 53 positions worth $95M, up 1.5% from $93.5M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Scholtz & Company's Q4 2015 filing shows 6 new, 22 increased, 12 reduced and 11 closed positions. Its largest new stake was CVS Health: 43,665 shares worth $4.27M. The largest sale was Jernigan Capital, Inc., an estimated $2.25M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Scholtz & Company's largest Q4 2015 buy was CVS Health: 43,665 shares worth $4.27M.
  • Scholtz & Company added most to Time Warner Inc in Q4 2015, an estimated $1.62M increase.
  • Scholtz & Company's biggest Q4 2015 reduction was FedEx, cutting an estimated $2.06M.
  • Scholtz & Company fully exited Jernigan Capital, Inc. in Q4 2015, selling an estimated $2.25M.
  • Scholtz & Company's ten largest holdings make up 46% of its $95M portfolio in Q4 2015.
  • Scholtz & Company opened 6 new positions and closed 11 in Q4 2015.
  • Scholtz & Company's portfolio value rose 1.5% quarter-over-quarter to $95M.

Based on Scholtz & Company's 13F filing for Q4 2015, filed 12 Feb 2016.